The global Vitamin D Therapy market accrued revenue worth nearly 2 (USD Billion) in 2019 and record a CAGR of about 11.7 % over the period from 2020 to 2026. The report offers assessment and analysis of the Vitamin D Therapy market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, sales estimates, opportunities, evolving trends, and industry-validated data. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).
Introduction
Vitamin D, which is a kind of lipophilic vitamin, comprises of a cluster of fat-soluble seco-sterols and is identified as rapidly soluble prohormone that aids in controlling of phosphate & calcium metabolism. Two types of vitamins are available in market and are referred to as vitamin D2 and vitamin D3. Vitamin D2 is generally made by humans and fortified with diet. It is found in mushrooms and has plant source. In case of D3, it is synthesized in the skin of humans from 7-dehydrocholesterol and can also be availed via the intake of animal-based diets including cod-liver oil, egg yolk, and meat of fatty fish. A key aspect of vitamin D is that it can be synthesized by the human body with the help of sun rays.
Furthermore, food supplements comprising of vitamin D are consumed more frequently across the globe in the recent times. Vitamin D used in supplement products are either in the form of vitamin D2 or vitamin D3. Moreover, Vitamin D supplements are also available commercially in form of oily drops, tablets, and capsules.
Details of the Report:
Market Growth Drivers
Vitamin D deficiency results in lack of the bone mineralization leading to various disorders in adults such as bone fractures, osteomalacia, and osteoporosis. Additionally, it can also treat hyperparathyroidism in adults. Hence, Vitamin D treatment helps in avoiding occurrence of these aforementioned diseases in adults. Apart from this, the product has also been utilized for preventing rickets in the children. This will unlock new growth avenues for the market over the years ahead.
Apparently, it has been found that calcitriol -an active Vitamin D Route of Administration- helps in controlling manifold cellular processes including normal & malignant cell proliferation. It also assists in regulating heart and immune functions in the humans. As per NCBI, clinical research has proved the significance of vitamin D in prevention of cancer. It has also been found that vitamin D therapy has benefited patients affected due to ailments such as diabetes, autoimmune disorders, psoriasis, and heart disease. Moreover, vitamin D treatment has proved to be beneficial for people having impaired skeletal disorders. Apparently, vitamin D is delivered in humans through drug delivery systems, food fortification, or dietary supplements for treating both non-skeletal as well as skeletal disorders. All these aforementioned factors are expected to chart a profitable growth graph for the vitamin D therapy market in the near future as well as for the next decade.
Furthermore, older persons who intake inadequate proportion of vitamin D in diet, low exposure to sun, diminished dermal conversion of 7-dehydrocholesterol to vitamin D3, and secondary hyperparathyroidism are at prone to suffer from poor bone health as well as osteoporotic fractures. This will further drive the market growth over the forecast timespan.
According to Lancet, vitamin D deficiency is one of the key causes of death across various countries. Reportedly, the observations made in the study published in the journal state that out of twenty European countries, the average vitamin D proportion is low in the inhabitants of Italy and Spain. Moreover, it has been confirmed that these nations have observed high coronavirus deaths in comparison to the number of deaths witnessed in north European countries where high vitamin D proportions are found in the persons due to intake of cod liver oil as well as vitamin D supplements. This has proved that Vitamin D can enhance the immunity of individuals against CoVID-19 to a larger extent. This will expand the scope of vitamin D therapy market over the coming years.
According to WHO, Vitamin D plays the role of immunomodulation, enhancing immune system and boosting mucosal defenses to offer protection to the human body from infection and cancer. Furthermore, it also helps in prevention of respiratory tract ailments.
Asia Pacific to dominate the overall market growth during 2020-2026
The regional market growth over the forecast period is owing to high percentage of vitamin D insufficiency witnessed in nearly over 70.1% population in the countries like India. According to NCBI, Vitamin D deficiency is projected to play a pivotal role in the huge occurrence of diseases such as rickets, cancer, cardiovascular diseases, osteoporosis, diabetes, and tuberculosis in the country.
In addition to this, NIH researchers have observed that widely consumed food items such as dairy products sold in India are rarely fortified with vitamin D. Additionally, low exposure to sunlight is expected to influence the demand for vitamin D treatment in the country. Furthermore, large percentage of Indian population intake vegetarian food and studies have revealed that proportion of Vitamin D is less in vegetarian diet as the high fiber content & large proportion of phytate present in the vegetarian reduce the absorption of vitamin D. This will generate huge demand for vitamin D treatment in the country, thereby embellishing the regional market trends over the next couple of years.
Moreover, the inadequacy of Vitamin D witnessed in the Asian countries has created huge health issues, thereby generating humongous demand for functional foods fortified with vitamin D during food processing in the region. This will generate huge market demand within the span of next few years.
Key players profiled in the report include Novartis International AG, Torrent Pharmaceuticals Ltd., Abbott, Merck & Co., Inc., Sanofi, Cadila Healthcare Ltd., Pfizer, Inc., Merck & Co., Inc., and Sun Pharmaceutical Industries Ltd.
The report segments the global vitamin D therapy market as follows:
By Route of Administration
- Oral
- Parenteral
By Purchasing Pattern
- OTC Drugs
- Prescription Drugs
By Application
- Osteoporosis
- Rickets
- Skin Diseases
- Muscle Weakness
- Autoimmune Disorders
- Others
By Age Group
- Children
- Adults
- Senior Adults
By Region
- North America
- The U.S.
- Canada
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Frequently Asked Questions
The key growth drivers that will leverage the market growth include massive need of vitamin D therapy for preventing the diseases like rickets, bone fractures, osteomalacia, and osteoporosis in children & adults
The CAGR of the industry is expected to be nearly 11.7 % during the forecast timespan.
Asia Pacific region will contribute remarkably towards the global market share over the estimated timeline.
The key market participants include Novartis International AG, Torrent Pharmaceuticals Ltd., Abbott, Merck & Co., Inc., Sanofi, Cadila Healthcare Ltd., Pfizer, Inc., Merck & Co., Inc., and Sun Pharmaceutical Industries Ltd.
